Concepedia

Jo Dole

JD

4

Publications

1.2K

Citations

4

H-Index

2001

Active since

Affiliations

GlaxoSmithKline (United States)(Current)

Dallas Diabetes Research Center

Creighton University

Jo Dole is an author at GlaxoSmithKline (United States).

Publications per year

2001–2020

4

Publications

4

Rosiglitazone Monotherapy Is Effective in Patients with Type 2 Diabetes

Harold E. Lebovitz, Jo Dole, Rita Patwardhan et al. · The Journal of Clinical Endocrinology & Metabolism · 2001 · 503 citations · Full text

A Randomized Trial of Rosiglitazone Therapy in Patients With Inadequately Controlled Insulin-Treated Type 2 Diabetes

Philip Raskin, Marc Rendell, Matthew C. Riddle et al. · Diabetes Care · 2001 · 343 citations · Full text

A Comparison of the Effects of Rosiglitazone and Glyburide on Cardiovascular Function and Glycemic Control in Patients With Type 2 Diabetes

Martin St. John Sutton, Marc Rendell, Paresh Dandona et al. · Diabetes Care · 2002 · 254 citations

Impact of a Weekly Glucagon-Like Peptide 1 Receptor Agonist, Albiglutide, on Glycemic Control and on Reducing Prandial Insulin Use in Type 2 Diabetes Inadequately Controlled on Multiple Insulin Therapy: A Randomized Trial

Julio Rosenstock, Antonio Nino, Joseph Soffer et al. · Diabetes Care · 2020 · 67 citations · Full text

Rows per page

1–4 of 4